期刊文献+

托吡酯的合成研究进展 被引量:3

Progress in Synthesis of Topiramate
原文传递
导出
摘要 目的介绍托吡酯的研究背景和合成研究进展。方法综合国内外报道的文献,阐述托吡酯的合成方法。结果重点列出了关键中间体的合成方法以及酯化法、氨解法、催化氢化法和水解法4种托吡酯的合成方法,分析各方法特点。结论氨解法是托吡酯合成方法的主要研究方向。 OBJECTIVE To introduce the background and current synthesis progress of topiramate. METHODS To review both domestic and international published reports regarding the synthesis of topiramate. RESULTS Made a list of synthesis methods of a key intermediate and four synthesis methods of topiramate including esterification, ammonolysis, catalytic hydrogenation and hydrolyzation and analyzing characteristics of synthesis methods. CONCLUSION The method of ammonolysis provides us a main research direction for efficient synthesis topiramate.
作者 苗宇 关永霞
出处 《中国现代应用药学》 CAS CSCD 2013年第4期453-456,共4页 Chinese Journal of Modern Applied Pharmacy
关键词 托吡酯 合成 进展 topiramate synthesis progress
  • 相关文献

参考文献21

  • 1HU Y H, SHAO S Q, SHI S G. The research advancement oftopiramate in the prevention of migraine [J].中国疼痛医学杂志,2010,16(2): 100-102.
  • 2孙曼莉,肖农.托吡酯治疗儿童偏头痛的研究进展[J].儿科药学杂志,2012,18(1):53-56. 被引量:3
  • 3KAPLAN L M. Pharmacologic therapies for obesity [J].Gastroenterol Clin North Am, 2010, 9(1): 69-79.
  • 4MA P Q. Status and progress in studies on anti obesity drugs [J].上海医药,2011,32(6): 304-307.
  • 5YANG W Z. Progress in study on neuroprotection oftopiramate [J].临床和实验医学杂志,2010,9(19): 1511-1513.
  • 6LIU J B, SHI J P, ZHAO X X. Advances in neuroprotectiveeffects of topiramate [J]. 临床神经病学杂志,2005,18(4):317-318.
  • 7马建华,李雅忠,刘忠,王立娟,刘海军.托吡酯治疗酒依赖临床疗效观察[J].中国健康心理学杂志,2011,19(2):156-158. 被引量:6
  • 8MARYANOFF B E, NORTEY S 0,GARDOCKI J F, et al.Anticonvulsant O-alkyl sulfamates. 2,3:4,5-bis-0-( 1 -methyl-ethylidene)-beta-Z)-fructopyranose sulfamate and relatedcompounds [J]. J Med Chem, 1987, 30(5): 880-887.
  • 9MARYANOFF C A,SCOTT L, SORGI K L. Two stepmethod for the preparation of sulfamate derivatives: China,92111591.1[P]. 1993-08-18.
  • 10ZHUO C, CHENG G H. Synthesis of topiramate [J]. 中国医药工业杂志,1999, 30(11): 486-487.

二级参考文献46

  • 1金瑞峰,孙若鹏,王莹.托吡酯在非抗癫痫方面的临床应用新进展[J].中国新药与临床杂志,2005,24(10):818-823. 被引量:4
  • 2楼东东.妥泰在临床中的应用[J].牡丹江医学院学报,2006,27(4):59-61. 被引量:7
  • 3Rustembegovic A, Sofic E, Kroyer G. A pilot study of topiramate (Topamax)in the treatment of tonic--clonic seizures of alcohol with- drawal syndromes[J]. Med Arh, 2002,56 (4) : 211-212.
  • 4Johnson B A,Ait-Daoud N, Bowden C L,et al. Oral topiramate ofr treatment of alcohol dependence: a randomized controlled trial[J]. Lancet, 2003,361 (9370) : 1677-1685.
  • 5Johnson B A, Ait- Daoud N, Akhtar F Z, et al. Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol--dependence individuals: a randomized controlled trial[J]. Arch Gen Psychiatry, 2004,61 ( 9 ) : 905-912.
  • 6Maryanoff BE, Nortey SO, Gardocki JF, et al. Anticonvulsant O-alkyl sulfamates. 2,3:4,5-bis-O- (1-methylethylidene) -β- D-fructopyranose sulfamate and related compounds [J]. J Med Chem, 1987, 30 (5) : 880-887.
  • 7Winum JY, Vullo D, Casini A, et al. Carbonic anhydrase inhibitors. Inhibitors of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors [J]. J Med Chem, 2003, 46 (11) : 2197-2204.
  • 8Maryanoff BE, Hope N, Gardocki JF, et al. Anticonvulsant sulfamate derivatives: US, 4513006 [P]. 1985-04-23. (CA 1985, 103: 37701).
  • 9Maryanoff BE, Hope N, Gardocki JF, et al. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol: US, 4582916 [P]. 1986-04-15. (CA 1985, 103: 37701).
  • 10Singh CHP, Shankar CA, Mafatlal PS, et al. An improved process for the manufacture of topiramate: WO, 2007099388 [P]. 2007-09-07. (CA2007, 147: 323223).

共引文献7

同被引文献44

  • 1黄琳,王玉.偏头痛与癫痫关系的最新进展[J].中华临床医师杂志(电子版),2011,5(16):4791-4794. 被引量:12
  • 2单靖珊.托吡酯的临床应用[J].天津药学,2005,17(2):63-65. 被引量:1
  • 3吴江,贾建平,崔丽英.神经病学[M].2版.北京:人民卫生出版社,2013:155-158.
  • 4Miller S, Matharu MS. Migraine is underdiagnosed and undertreated[J]. Practitioner 2014, 258(1774): 19-24, 2-3.
  • 5Martelletti P. The therapeutic armamentarium in migraine is quite elderly[J]. Expert Opin Drug Metab Toxicol, 2,01S, 11 (2): 175-177.
  • 6Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010[J]. Lancet, 2,012, 380(9859): 2163-2,196.
  • 7Estemalik E, Tepper S. Preventive treatment in migraine and the new US guidelinesIJ]. Neuropsychiatr Dis Treat, 2013 9: 709-72,0.
  • 8Linde M, Mulleners WM, Chronicle EP, et al. Antiepihptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults (Review)[J]. Cochrane Database Syst Rev, 2013, 6: CD010608.
  • 9Naegel S, Obermann M. Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference [J]. Neuropsychiatr Dis Treat, 2010j 6: 17-28.
  • 10Ferrari A, Tiraferri I, Neri L, et al. Clinical pharmacology of topiramate in migraine prevention[J]. Expert Opin Drug Metab Toxicol, 2011, 7(9): 1169-1181.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部